Search Results 931-940 of 18118 for corticosteroid

1. ESG Use for Weight Loss in Obese UC Patients Undergoing Colectomy With IPAA - Mayo Clinic

   Ongoing corticosteroid use at a dose of > 5 mg daily. Daily use of anti-inflammatory agents such as non-steroidal medications, or anticoagulants without ...

2. LIPS-B: Lung Injury Prevention Study with Budesonide and Beta - Mayo Clinic

   Inhaled corticosteroid and/or beta agonist treatment on admission or within 7 days prior to admission (history of asthma or COPD necessitating therapy) ...

3. Mayo Clinic Q and A: Ongoing insomnia? Variety of factors could be at play

   They include heart and blood pressure medications, allergy medications, stimulants such as Ritalin, and corticosteroids, among others. Many over-the-counter ...

4. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   Inhaled and topical corticosteroids are permitted. Refer to Appendix C for a corticosteroid dose conversion table. Women of childbearing potential (WOCBP) ...

5. Mayo Clinic Q and A: Treating gout involves combination of lifestyle changes, medication

   Corticosteroid medications, such as prednisone, also may be used to control gout. Due to the potential for significant side effects, however, corticosteroids ...

6. Inflammatory bowel disease (IBD) - Symptoms and causes - Mayo Clinic

   Corticosteroids can be associated with a risk of osteoporosis, high blood pressure and other conditions. Primary sclerosing cholangitis. In this uncommon ...

7. Hydroxyzine (oral route) - Side effects & dosage - Mayo Clinic

   This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet; Syrup; Capsule. Back to top ...

8. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab - Mayo Clinic

   ... corticosteroid (OCS) dose \<=7.5 mg/day of prednisolone or equivalent ... Receipt of intravenous/intramuscular/subcutaneous corticosteroids within 4 ...

9. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

   − Corticosteroids (≤10 mg/day prednisone or equivalent); − Omalizumab ... Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2. For patients ...

10. A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) - Mayo Clinic

    ... corticosteroids must be discontinued at least 4 weeks prior to dosing. Inhaled or intranasal corticosteroids (with minimal systemic absorption) may be ...